The plant-based reset is no longer a rumor — it’s showing up on the factory floor. On September 22, 2026, Maple Leaf Foods Inc. (TSX: MFI) said it will consolidate all of its U.S. plant protein production into a single Plant Protein Centre of Excellence in Indianapolis, Indiana, and wind down its plants in Seattle, Washington and Turners Falls, Massachusetts by Q4 2027.
For anyone tracking the trajectory of meatless food, this is a headline worth reading twice. One of North America’s most prominent protein CPG companies isn’t exiting plant-based — it’s restructuring to survive and win in a category that has cooled dramatically from its peak.
The Mississauga, Ontario-based company will move U.S. plant protein manufacturing into its Indianapolis facility, designating it a Centre of Excellence. The transition will roll out in phases over roughly 12 to 18 months, with targeted completion in Q4 2027. Production continues at Seattle and Turners Falls throughout the transition to protect customer service and enable an orderly transfer.
The move is part of Maple Leaf Foods’ Fuel for Growth initiative and follows a review of its plant protein manufacturing footprint. According to the company, consolidation is expected to:
- Create a more efficient manufacturing network
- Improve capacity utilization
- Reduce operational complexity
- Establish a focused Centre of Excellence with the scale to support its plant protein brands more competitively
As production shifts, Maple Leaf Foods expects to invest in the Indianapolis facility and add team members to support its expanded scope.
Why the Category Forced the Decision
Curtis Frank, President and Chief Executive Officer of Maple Leaf Foods, was candid about the pressures reshaping the business…